ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

August 04, 2009 13:13 ET

ProMetic Announces Date for Second Quarter 2009 Financial Results and Conference Call

MONTREAL, QUEBEC, CANADA--(Marketwire - Aug. 4, 2009) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announces that it will release its second quarter 2009 financial results after the close of market on Wednesday, August 5, 2009.

A conference call and webcast will be held on Thursday, August 6, 2009, at 10:30 (EDT). The numbers to access the conference call are (416) 620-2407 (international) and 1 (800) 215-1640 (toll free). A live audio webcast of the conference call will be available through ProMetic's website at

A replay of the call will be available by telephone for a period of seven days as of Thursday, August 6, 2009, at 12:30 (EDT). The numbers to access the audio replay are (416) 626-4100 (international) and 1 (800) 558-5253 (toll free) using access code 21433585. The replay of the web cast may be downloaded directly from ProMetic's web site.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the US and Canada, manufacturing facilities in the UK and business development activities in the US, Europe, Asia and in the Middle-East.

Contact Information